Curaleaf Achieves Groundbreaking Registration for Cannabis Products in Spain

Curaleaf Holdings, Inc., a prominent name in the international cannabis market, has recently reached a significant milestone by becoming the first company to secure registration for standardized cannabis preparations in Spain. This monumental move came after the Spanish Agency of Medicines and Medical Devices (AEMPS) gave formal approval for Curaleaf's THC-dominant and CBD-dominant products. With this registration, Curaleaf is now positioned to supply these standardized preparations to hospital pharmacies, where they'll be utilized in creating magistral formulas according to medical prescriptions. This landmark achievement aligns with the new regulatory framework established by Royal Decree 903/2025, which the Spanish Council of Ministers approved on October 7, 2025. This legislation provides a clear structure for the medicinal use of standardized cannabis in Spain, setting forth production requirements, quality standards, and regulatory pathways for registration. By marking one of the first instances of such products being formally recognized in the country, Curaleaf not only emphasizes its commitment to advancing the cannabis industry but also heralds improved access to quality medicines for patients across Spain. The company has long maintained a robust presence in the Spanish market, utilizing an EU-GMP certified manufacturing facility along with a research and development laboratory located in Alicante. This recent achievement builds on earlier successes, including a notable event in May 2020 when Curaleaf's EU-GMP laboratory, Medalchemy SL, became the first to secure a license from the AEMPS for the processing of medicinal cannabis derivatives for commercial distribution. This foundational victory set the stage for today's triumph. Boris Jordan, Curaleaf's CEO, emphasized the significance of this registration for the company and its vision for Europe, describing Spain, with its population of nearly 50 million, as central to Curaleaf’s aspirations. He highlighted the company's historical importance in the region, being the first to obtain a license in 2020 and now the first to register under the current regulatory framework. Jordan stated, 'This achievement reflects the strength of our team, our sustained investment in science, and our conviction that patients deserve access to standardized, high-quality cannabis medicines.' With the required regulatory approvals in place, Curaleaf anticipates these standardized preparations will soon be accessible to patients through hospital pharmacies. The company is committed to collaborating with healthcare professionals and partners to facilitate access as Spain's regulated framework evolves. Curaleaf Holdings, Inc. is recognized as a leading international provider of cannabis consumer products, driven by a mission to enhance lives by leveraging the therapeutic benefits of the cannabis plant. As a high-growth entity, Curaleaf is celebrated for its reliable quality and expertise within the cannabis sector, operating a diverse portfolio of well-known brands such as Select, Grassroots, Find, Dark Heart, and Anthem. The company’s strategic presence spans all facets of the cannabis supply chain, seamlessly integrating pioneering research with advanced cultivation, extraction, and production. Investors are reminded that the information herein may include forward-looking statements, which inherently involve risks and uncertainties. Specific timelines for product availability through the healthcare system depend on compliance with new regulatory requirements and the discretion of health authorities. Curaleaf remains focused on adaptation, innovation, and patient access in this evolving landscape, reinforcing its commitment to quality and patient care. As Curaleaf continues to navigate the complexities of the cannabis market, its groundbreaking registration in Spain not only solidifies its position as a leader in the industry but also signifies a pivotal step towards enhancing the availability of medicinal cannabis to those in need.